A bivalent Neisseria meningitidis recombinant lipidated factor H binding protein vaccine in young adults: Results of a randomised, controlled, dose-escalation phase 1 trial
| Autor: | Richmond, P.C., Nissen, M.D., Marshall, H.S., Lambert, S.B., Roberton, D., Gruber, W.C., Jones, T.R., Arora, A. |
|---|---|
| Zdroj: | In Vaccine 21 September 2012 30(43):6163-6174 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect